Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating cardiac biomarkers and postoperative atrial fibrillation in the OPERA trial.
Masson S, Wu JH, Simon C, Barlera S, Marchioli R, Mariani J, Macchia A, Lombardi F, Vago T, Aleksova A, Dreas L, Favaloro RR, Hershson AR, Puskas JD, Dozza L, Silletta MG, Tognoni G, Mozaffarian D, Latini R; OPERA Investigators. Masson S, et al. Among authors: barlera s. Eur J Clin Invest. 2015 Feb;45(2):170-8. doi: 10.1111/eci.12393. Epub 2015 Jan 7. Eur J Clin Invest. 2015. PMID: 25510286 Free article. Clinical Trial.
Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN; Val-HeFT Investigators. Masson S, et al. Among authors: barlera s. Clin Chem. 2006 Aug;52(8):1528-38. doi: 10.1373/clinchem.2006.069575. Epub 2006 Jun 15. Clin Chem. 2006. PMID: 16777915 Free article.
Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial.
Masson S, Aleksova A, Favero C, Staszewsky L, Bernardinangeli M, Belvito C, Cioffi G, Sinagra G, Mazzone C, Bertocchi F, Vago T, Peri G, Cuccovillo I, Masuda N, Barlera S, Mantovani A, Maggioni AP, Franzosi MG, Disertori M, Latini R; GISSI-AF investigators. Masson S, et al. Among authors: barlera s. Heart. 2010 Dec;96(23):1909-14. doi: 10.1136/hrt.2009.191460. Epub 2010 Oct 21. Heart. 2010. PMID: 20965978 Clinical Trial.
Adiponectin in chronic heart failure: influence of diabetes and genetic variants.
Masson S, Gori F, Latini R, Milani V, Flyvbjerg A, Frystyk J, Crociati L, Pietri S, Vago T, Barlera S, Maggioni AP, Tognoni G, Tavazzi L, Omland T, Franzosi MG; GISSI-HF Investigators. Masson S, et al. Among authors: barlera s. Eur J Clin Invest. 2011 Dec;41(12):1330-8. doi: 10.1111/j.1365-2362.2011.02548.x. Epub 2011 May 30. Eur J Clin Invest. 2011. PMID: 21623778 Clinical Trial.
Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial.
Latini R, Masson S, Pirelli S, Barlera S, Pulitano G, Carbonieri E, Gulizia M, Vago T, Favero C, Zdunek D, Struck J, Staszewsky L, Maggioni AP, Franzosi MG, Disertori M; GISSI-AF Investigators. Latini R, et al. Among authors: barlera s. J Intern Med. 2011 Feb;269(2):160-71. doi: 10.1111/j.1365-2796.2010.02287.x. Epub 2010 Oct 22. J Intern Med. 2011. PMID: 20964739 Free article. Clinical Trial.
Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.
Masson S, Anand I, Favero C, Barlera S, Vago T, Bertocchi F, Maggioni AP, Tavazzi L, Tognoni G, Cohn JN, Latini R; Valsartan Heart Failure Trial (Val-HeFT) and Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca–Heart Failure (GISSI-HF) Investigators. Masson S, et al. Among authors: barlera s. Circulation. 2012 Jan 17;125(2):280-8. doi: 10.1161/CIRCULATIONAHA.111.044149. Epub 2011 Dec 2. Circulation. 2012. PMID: 22139751 Clinical Trial.
Cardiac Remodeling, Circulating Biomarkers and Clinical Events in Patients with a History of Atrial Fibrillation. Data from the GISSI-AF Trial.
Staszewsky L, Masson S, Barlera S, Disertori M, Boni S, Bertoli D, Vriz O, Pasotti E, Zeni P, Vago T, Maggioni AP, Tognoni G, Latini R; on the behalf of the GISSI-AF Investigators. Staszewsky L, et al. Among authors: barlera s. Cardiovasc Drugs Ther. 2015 Dec;29(6):551-561. doi: 10.1007/s10557-015-6624-3. Cardiovasc Drugs Ther. 2015. PMID: 26546322
103 results